Skip to main content
. 2022 Jan;28(1):10.18553/jmcp.2022.28.1.58. doi: 10.18553/jmcp.2022.28.1.58

TABLE 3.

Patients Receiving At Least 15 DME per Day from the Rhode Island Prescription Drug Monitoring Program in 2018a

Patient demographics Patients with a benzodiazepine prescription, n (%) Patients with a benzodiazepine dose ≥ 15 DME/day, n (%)
Overall 143,026 (100) 37,455 (26.2)
Sexb
  Male 48,106 (33.6) 14,556 (30.3)
  Female 94,884 (66.3) 22,883 (24.1)
Age, years
  18-34 18,672 (13.1) 4,143 (22.2)
  35-49 31,007 (21.7) 9,027 (29.1)
  50-64 49,444 (34.6) 14,401 (29.1)
  65-74 25,745 (18.0) 6,651 (25.8)
  75+ 18,158 (12.7) 3,233 (17.8)
Payment
  Commercial insurance 65,835 (46.0) 15,105 (22.9)
  Medicaid 17,433 (12.2) 6,177 (35.4)
  Medicare < 65 9,478 (6.6) 4,378 (46.2)
  Medicare 65+ 30,635 (21.4) 7,342 (24.0)
  Cash 15,203 (10.6) 3,209 (21.1)
  Other 4,442 (3.2) 1,244 (28.0)
County
  Providence 67,293 (47.0) 18,939 (28.1)
  Kent 24,844 (17.4) 7,005 (28.2)
  Washington 15,383 (10.8) 3,805 (24.7)
  Bristol 5,775 (4.0) 1,375 (23.8)
  Newport 8,825 (6.2) 2,060 (23.3)
  Out of state 20,906 (14.6) 4,271 (20.4)
Concurrent opioid use
  Yes 20,168 (14.1) 7,537 (37.4)
  No 122,858 (85.9) 29,918 (24.4)
Concurrent stimulant use
  Stimulant 9,547 (6.7) 3,760 (39.4)
  No stimulant 133,478 (93.3) 33,695 (25.2)

a According to the patient’s most recent benzodiazepine dispensing.

b Sex was missing for 36 patients.

DME = diazepam milligram equivalents.